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Placement of Electrode Catheters into the Coronary Sinus During 
Electraphysiology Procedures Using a Femoral Vein Approach 
Emile G. Daoud, MD, Mark Niebauer, MD, Omar Bakr, MD, John Jentzer, MD, K. Ching Man, DO, 
Brian D. Williamson, MD, John D. Hummel, MD, S. Adam Strickberger, MD, and Fred Morady, MD 
E lectrograms recorded from within the coronary sinus provide useful diagnostic and mapping data in pa- 
tients undergoing electrophysiologic procedures for man- 
agement of paroxysmal supraventricular tachycardia or 
Wolff-Parkinson-White syndrome.1~2 Conventionally, an 
electrode catheter is inserted into the coronary sinus us- 
ing a subclavian, internal jugular, or brachial vein ap- 
proach. 3p4 However, it is also possible to catheterize the 
coronary sinus using a femoral vein approach, thereby 
eliminating the need for any venous access other than the 
femoral vein. The purpose of this study was to prospec- 
tively assess the feasibility of placing an electrode cath- 
eter into the coronary sinus using a femoral vein ap- 
proach. 
The subjects of this study were 10.5 consecutive pa- 
tients who underwent an electrophysiologic procedure 
at the University of Michigan Medical Center. In 85 pa- 
tients, a femoral vein approach was used to catheterize 
the coronary sinus. In 20 patients who were undergoing 
evaluation of a recently implanted internal cardioverterl 
de$brillator, the electrophysiologic procedure was per- 
formed with a single electrode catheter using an inter- 
nal jugular or subclavian vein approach. Patients who 
underwent the femoral vein approach had a mean age 
(+ SD) of 45 + 18 years and 60 of 85 patients (70%) 
had no structural heart disease. Patients who underwent 
an internal jugular or subclavian vein approach had a 
mean age of 58 f 15 years and only I of 20 patients 
(5%) did not have structural heart disease. 
Among the 85 patients who underwent a femoral vein 
approach, 3 sheaths were inserted into the right femoral 
vein and 3 6Fr or 7Fr electrode catheters were posi- 
tioned in the right atrium, His bundle position, and right 
ventricle. At least 1 of these catheters had a deflectable 
tip (Mansfield, Watertown, Massachusetts). After base- 
line electrophysiologic measurements were obtained, the 
deflectable tip catheter was directed into the coronary 
sinus under fluoroscopic guidance using a 60” left an- 
terior oblique view (Figure 1). The amount of time re- 
From the Division of Cardiology, Department of Medicine, University 
of Michigan Medical-Center, 1500 East Medical Center Drive, Ann 
Arbor, Michigan 48109-0022. Manuscript received October 19, 1993; 
revised manuscript received and accepted December 14, 1993. 
quired to maneuver the catheter from its prior position 
into the lateral coronary sinus was measured with a stop- 
watch. Among the 20 patients who underwent an inter- 
nal jugular or subclavian vein approach, the deflectable 
tip catheter was inserted through a sheath placed into 
the leji subclavian or right internal jugular vein and ma- 
neuvered into the coronary sinus. The time required to 
cannulate the vein and catheterize the coronary sinus 
was measured. With both approaches, a second opera- 
tor attempted to catheterize the coronary sinus tfthejirst 
operator was not successful within 15 minutes. 
Continuous variables are expressed as mean + SD 
and were compared using the Student’s t test. A p value 
~0.05 was considered significant. 
Using the femoral vein approach, the coronary sinus 
was successfully catheterized in 84 of 85 patients (99%) 
in a mean of 1.2 + 2.3 minutes. The catheterization was 
achieved by the first operator in 92% of patients and by 
RBURE 1. Fluoroscopic 00” left anterior oblique view of 
a deflectable catheter in the coronary sinus (CS). 
Catheters In the His bundle (HB) position and right 
atrium (RA) are also shown. With an appropriate degree 
of tip deflection, the anticipated region of the coronary 
sinus ostium was probed with the catheter until the 
coronary sinus was entered. 
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a second operator in 7%. The coronary sinus could not 
be successfully catheterized in an obese patient with di- 
lated cardiomyopathy and 4-chamber cardiac enlarge- 
ment. Catheterization of the coronary sinus was suc- 
cessful in each of the 20 patients who underwent the 
internal jugular or subclavian approach, and the mean 
time required to achieve catheterization was 12.5 f IO 
minutes, which was significantly longer than with the 
femoral vein approach (p <O.OOl). There were no com- 
plications in any of the patients in this study. 
The results of this study demonstrate that catheteri- 
zation of the coronary sinus during an electrophysiologic 
procedure can almost always be accomplished in a brief 
period of time using a deflectable tip catheter inserted 
into a femoral vein. The femoral vein approach saves 
time because it precludes the need for cannulation of the 
subclavian, internal jugular, or brachial vein. The possi- 
ble complications associated with an internal jugular or 
subclavian vein approach are avoided, including pneu- 
mothorax, hemothorax, thoracic duct injury, laceration 
of a carotid or cervical artery, brachial plexus injury, tra- 
cheal perforation, air embolism, and aortic puncture.5*6 
The femoral vein approach also has a cost advantage 
over the internal jugular and subclavian approaches. Be- 
cause it is quicker, the laboratory charge for the elec- 
trophysiologic procedure is lower than when additional 
time is spent cannulating a vein other than the femoral 
vein. Because one of the three catheters inserted for base- 
line measurements is used, the expense of a fourth ve- 
nous access kit and electrode catheter is spared. In ad- 
dition, a postprocedure chest x-ray is not necessary to 
rule out a pneumothorax when the femoral vein approach 
is used. The cost savings associated with use of the 
femoral vein approach instead of a subclavian or inter- 
nal jugular approach may often total several hundred dol- 
lars per patient. 
The femoral vein approach used in this study has 
2 limitations. First, it requires the use of a deflectable 
tip catheter, which typically is $200 to $300 more ex- 
pensive than a standard electrode catheter. Second, 
with the femoral vein approach used in the present 
study, the total number of pacing and recording sites 
is limited to 3. However, because the coronary sinus 
catheter can be used for atria1 pacing, and because 
the right atria1 electrogram is rarely required for di- 
agnostic purposes, we have found the combination of 
the coronary sinus, His bundle electrogram, and right 
ventricular apex positions to be adequate in virtually 
all patients undergoing an electrophysiologic proce- 
dure in whom coronary sinus electrograms are needed 
for a diagnostic or mapping purpose. 
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The Effects of Adenosine on Idiopathic Ventricular Tachycardia 
Kheng-Siang Ng, MBBS, MRCP, Ming-Shien Wen, MD, San-Jou Yeh, MD, Fun-Chung Lin, MD, and Delon Wu, MD 
V entricular tachycardia (VT) in the absence of struc- tural heart disease is an uncommon but well-recog- 
nized entity. Two clinical forms have often been ob- 
served: (1) verapamil-sensitive VT characterized by 
right bundle branch block (RBBB) morphology with a 
superior frontal plane axis, and (2) catecholamine-sen- 
sitive VT characterized by left bundle branch block 
(LBBB) morphology with an inferior frontal plane axis. 
The former typically originates from the inferoapical 
portion of the left ventricle, can be initiated by pro- 
grammed stimulation, and terminated with intravenous 
verapamil, 1,2 whereas the latter typically originates from 
the right ventricular outflow tract, requires adrenergic 
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stimulation for initiation, and can be terminated by both 
P-blocker and verapamil administration.3 Attempts have 
been made to identify the VT mechanism by response 
to programmed stimulation and pharmacologic manipu- 
lation (isoproterenol and verapamil), but the distinction 
between triggered automaticity and reentry remains po- 
tentially difficult.4 Lerman et al5 recently provided strong 
evidence for cyclic adenosine-3’5’-monophosphate-me- 
diated triggered automaticity as the mechanism in pa- 
tients in whom adenosine reliably terminated the tachy- 
cardia. The drug did not terminate tachycardia in patients 
with reentrant VT These observations suggest that 
adenosine may therefore be used as a diagnostic tool to 
distinguish the mechanism of VT We report the outcome 
of the effect of adenosine triphosphate on our series of 
patients with idiopathic VT. 
Drug testing with adenosine triphosphate was per- 
formed in 28 patients (19 males and 9 females, mean 
age 31 _+ I5 years, range 9 to 61) with electrocardio- 
graphic documentation of spontaneous idiopathic VT. 
All patients had normal results on clinical examination, 
chest x-ray, and 2-dimensional Doppler echocardiogra- 
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